-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MtgCTiTxotoKA1gwHVlGE0LZPlI4LCvJRZgPSo2kKuMXHdm58J+qVFkLcPNhBDsD hk13/zrLyppG6eSh0VnA5w== 0000950005-01-000081.txt : 20010209 0000950005-01-000081.hdr.sgml : 20010209 ACCESSION NUMBER: 0000950005-01-000081 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010208 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ILEX ONCOLOGY INC CENTRAL INDEX KEY: 0001001915 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-53221 FILM NUMBER: 1528801 BUSINESS ADDRESS: STREET 1: 11550 IH-10 WEST SUITE 100 CITY: SAN ANTONIO STATE: TX ZIP: 78230 BUSINESS PHONE: 2109498200 MAIL ADDRESS: STREET 1: 14785 OMICRON DR SUITE 101 CITY: SAN ANTONIO STATE: TX ZIP: 78245 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALTA PARTNERS CENTRAL INDEX KEY: 0001060013 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 943238854 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ONE EMBARCADERO CENTER STREET 2: STE 4050 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 4153624022 MAIL ADDRESS: STREET 1: ONE EMBARCADERO CENTER STREET 2: STE 4050 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 SC 13D/A 1 0001.txt SCHEDULE 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 UNDER THE SECURITIES EXCHANGE ACT OF 1934 Schedule 13D (Rule 13-d-102) INFORMATION STATEMENT PURSUANT TO RULES 13-D-1 AND 13-D-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) ILEX Oncology, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 451923106 (CUSIP Number) CUSIP No. 000451923106 13D Page 2 of 16 Pages
- ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Alta Partners - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization California - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A (13) Percent Of Class Represented By Amount In Row (11) Exit Filing (14) Type Of Reporting Person N/A *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 3 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Alta BioPharma Partners, L.P. - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization Delaware - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 4 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Alta Embarcadero BioPharma Partners, LLC - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization California - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 5 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons ILEX Chase Partners (Alta Bio), LLC - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization Delaware - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting (8) Shared Voting Power N/A Person With (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 0002078541 13D Page 6 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Alta BioPharma Management Partners, LLC - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization Delaware - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 7 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Alta/Chase BioPharma Management, LLC - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization Delaware - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 8 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Jean Deleage - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization U.S.A. - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 9 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Garrett Gruener - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization U.S.A. - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A- - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A (13) Percent Of Class Represented By Amount In Row (11) Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 10 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Daniel Janney - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization U.S.A. - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power 13,108 Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power 13,108 (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person 13,108 - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) 0.05% --- Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person IN - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 11 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Alix Marduel - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization U.S.A. - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power N/A- Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power N/A (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares* - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) _ Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person N/A - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 12 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Guy Nohra - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e): - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization U.S.A. - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power 7,945 Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power 7,945 (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person 7,945 - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) 0.03% ---- Exit Filing - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person IN - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
CUSIP No. 451923106 13D Page 13 of 16 Pages - ------------------------------------------------------------------------------------------------------------------- (1) Names of Reporting Persons. SS or I.R.S. Identification Nos. of Above Persons Marino Polestra - ------------------------------------------------------------------------------------------------------------------- (2) Check The Appropriate Box If A Member Of A Group N/A - ------------------------------------------------------------------------------------------------------------------- (3) SEC Use Only - ------------------------------------------------------------------------------------------------------------------- (4) Source Of Funds N/A - ------------------------------------------------------------------------------------------------------------------- (5) Check Box If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e:) - ------------------------------------------------------------------------------------------------------------------- (6) Citizenship Or Place Of Organization U.S.A. - ------------------------------------------------------------------------------------------------------------------- Number Of Shares (7) Sole Voting Power 27,945 Beneficially Owned By Each Reporting Person With (8) Shared Voting Power N/A (9) Sole Dispositive Power 27,945 (10) Shared Dispositive Power N/A (11) Aggregate Amount Beneficially Owned By Each Reporting Person 27,945 - ------------------------------------------------------------------------------------------------------------------- (12) Check If The Aggregate Amount In Row (11) Excludes Certain Shares N/A - ------------------------------------------------------------------------------------------------------------------- (13) Percent Of Class Represented By Amount In Row (11) 0.11% - ------------------------------------------------------------------------------------------------------------------- (14) Type Of Reporting Person IN - ------------------------------------------------------------------------------------------------------------------- *SEE INSTRUCTION BEFORE FILLING OUT!
Item 1. Security and Issuer. Exit Filing ---- All ILEX stock held by Alta BioPharma Partners, L.P., Alta Embarcadero BioPharma Partners, LLC and ILEX Chase Partners (Alta Bio), LLC was distributed to the respective general partners, limited partners and members of such funds on 2/23/00. This Statement on Schedule D relates to ILEX Corporation, a Delaware corporation (the "Company"). The principal executive offices of the Company are located at 11550 IH-10 West, Suite 300, San Antonio TX 78230-1064. Item 2. Identity and Background. (a) This Exit Filing is filed by Alta BioPharma Partners, L.P., a Delaware limited partnership ("Alta BioPharma"), and Alta Embarcadero BioPharma Partners, LLC, a California limited liability company ("Embarcadero LLC"), and ILEX Chase Partners (Alta Bio), LLC, a Delaware LLC ("ILEX Alta Bio") by virtue of their direct beneficial ownership of Shares, by Alta BioPharma Management Partners, LLC, a Delaware limited liability company ("Alta Management"), by virtue of being the sole general partner of Alta BioPharma, by Alta/Chase BioPharma Management LLC, a Delaware limited liability company (Alta/Chase Management) by virtue of being the sole managing director of ILEX Alta Bio and by Alta Partners, a California corporation ("Alta Partners"), by virtue of being the management advisory company of these entities. Alta BioPharma, Embarcadero LLC, ILEX Alta Bio, Alta Management, Alta/Chase Management and Alta Partners are collectively referred to as the "Reporting Persons." Jean Deleage, Garrett Gruener, Dan Janney, Alix Marduel, Guy Nohra and Marino Polestra (the "Partners") are the managing directors of Alta Management, Alta/Chase Management and officers of Alta Partners. By virtue of the relationships described above and their roles with Alta Partners, each of the Partners may be deemed to control Alta Partners, Alta/Chase Management, Alta Management, and, therefore, may be deemed to possess indirect beneficial ownership of the Shares held by each entity. However, none of the Partners, acting alone, has voting or investment power with respect to the Shares directly beneficially held by the entities and, as a result, the Partners disclaim beneficial ownership of the Shares directly beneficially owned by each entity, except to the extent of their pecuniary interest in each entity. Embarcadero LLC is a side company that makes all investments pro rata to the capital of Alta BioPharma with all allocations made to its members based on paid-in capital. Certain of the Partners are members of Embarcadero LLC and certain members of Embarcadero LLC are affiliates of Alta Partners. (b) The principal executive offices of Alta BioPharma, Embarcadero LLC, ILEX Alta Bio, Alta Management, Alta/Chase Management and Alta Partners, and the business address of each Partner, are located at One Embarcadero Center, Suite 4050, San Francisco, California 94111. (c) Alta Partners provides investment advisory services to venture capital firms. Alta BioPharma, ILEX Alta Bio and Embarcadero LLC's principal business is acting as venture capital investment vehicles. Alta/Chase Management and Alta Management's principal business is acting as managing director of ILEX Alta Bio and Alta BioPharma, respectively. Each of the Partners' principal business is acting as a managing director of Alta Management and Alta/Chase Management and as an officer of Alta Partners. (d) None of the Reporting Persons or, to the knowledge of the Reporting Persons, any of the Partners, has been convicted in a criminal proceeding in the past five years (excluding traffic violations or similar misdemeanors). (e) During the past five years, none of the Reporting Persons or, to the knowledge of the Reporting Persons, and none of the Partners, was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws of finding any violation with respect to such laws. (f) Alta Partners is a California corporation. Alta BioPharma is a Delaware limited partnership. Embarcadero LLC is a California limited liability corporation. ILEX Alta Bio is a Delaware limited liability company. Alta Management and Alta/Chase Management are Delaware limited liability companies. Each of the Partners is a citizen of the United States. Item 3. Source and Amount of Funds or Other Consideration. N/A Exit Filing All ILEX stock held by the Reporting Persons was distributed on 2/23/00. Item 4. Purpose of Transaction. Exit Filing All ILEX stock held by the Reporting Persons was distributed on 2/23/00. Item 5. Interest in Securities of the Issuer. Exit Filing Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Exit Filing Item 7. Material to be Filed as Exhibits. Exhibit A: Joint Filing Statement. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 5, 2001 ALTA PARTNERS ALTA BIOPHARMA PARTNERS, L.P. By: Alta BioPharma Management Partners, LLC By: /s/ Jean Deleage By: /s/ Daniel Janney --------------------------------- --------------------------------- Jean Deleage, President Daniel Janney, Managing Director ALTA BIOPHARMA MANAGEMENT PARTNERS, LLC ALTA EMBARCADERO BIOPHARMA PARTNERS, LLC By: /s/ Jean Deleage By: /s/ Jean Deleage --------------------------------- --------------------------------- Jean Deleage, Member Jean Deleage, Member ILEX CHASE PARTNERS (ALTA BIO), LLC ALTA/CHASE BIOPHARMA MANAGEMENT, LLC By: Alta/Chase BioPharma Management, LLC By: /s/ Daniel Janney By: /s/ Daniel Janney --------------------------------- --------------------------------- Daniel Janney, Member Daniel Janney, Member /s/ Jean Deleage /s/ Guy Nohra - ------------------------------------ ------------------------------------ Jean Deleage Guy Nohra /s/ Garrett Gruner /s/ Marino Polestra - ------------------------------------ ------------------------------------ Garrett Gruener Marino Polestra /s/ Daniel Janney /s/ Alix Marduel - ------------------------------------ ------------------------------------ Daniel Janney Alix Marduel
EXHIBIT A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13D is filed on behalf of each of us.
Date: February 5, 2001 ALTA PARTNERS ALTA BIOPHARMA PARTNERS, L.P. By: Alta BioPharma Management Partners, LLC By: /s/ Jean Deleage By: /s/ Daniel Janney --------------------------------- --------------------------------- Jean Deleage, President Daniel Janney, Managing Director ALTA BIOPHARMA MANAGEMENT PARTNERS, LLC ALTA EMBARCADERO BIOPHARMA PARTNERS, LLC By: /s/ Jean Deleage By: /s/ Jean Deleage --------------------------------- --------------------------------- Jean Deleage, Member Jean Deleage, Member ILEX JOLLA CHASE PARTNERS (ALTA BIO), LLC ALTA/CHASE BIOPHARMA MANAGEMENT, LLC By: Alta/Chase BioPharma Management, LLC By: /s/ Daniel Janney By: /s/ Daniel Janney --------------------------------- --------------------------------- Daniel Janney, Member Daniel Janney, Member /s/ Jean Deleage /s/ Guy Nohra - ------------------------------------ ------------------------------------ Jean Deleage Guy Nohra /s/ Garrett Gruener /s/ Marino Polestra - ------------------------------------ ------------------------------------ Garrett Gruener Marino Polestra /s/ Daniel Janney /s/ Alix Marduel - ------------------------------------ ------------------------------------ Daniel Janney Alix Marduel
-----END PRIVACY-ENHANCED MESSAGE-----